Get started
Work

Supplementary Methods from A Phase I, Open-Label Study of Siltuximab, an Anti–IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Methods - PDF file 88K, Supplementary methods for pharmacokinetic analyses and pharmacodynamic analyses
DOI: 10.1158/1078-0432.22451115.v1
Authors: Razelle Kurzrock, Peter M. Voorhees, Corey Casper, Richard R. Furman, Luis Fayad, Sagar Lonial, Hossein Borghaei, Sundar Jagannath, Lubomir Sokol, Saad Z. Usmani, Helgi van de Velde, Xiang Qin, Thomas A. Puchalski, Brett Hall, Manjula Reddy, Ming Qi, Frits van Rhee
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361908997
Cites: 2
Cited by:
Related to: 10